APA aipamena

Veazey, K. J., Cheng, D., Lin, K., Villarreal, O. D., Gao, G., Perez-Oquendo, M., . . . Santos, M. A. (2020). CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas. Leukemia.

Chicago Style aipamena

Veazey, Kylee J., et al. "CARM1 Inhibition Reduces Histone Acetyltransferase Activity Causing synthetic Lethality in CREBBP/EP300 Mutated lymphomas." Leukemia 2020.

MLA aipamena

Veazey, Kylee J., et al. "CARM1 Inhibition Reduces Histone Acetyltransferase Activity Causing synthetic Lethality in CREBBP/EP300 Mutated lymphomas." Leukemia 2020.